Clinical trials
Browse topics Search all clinical trials
The goal of Adaptive Interventions (AI) is to test the efficacy of brief treatment for individuals drinking at problematic levels. AI offers free treatment to individuals who are concerned about their drinking and allows them to choose whether they want to cut down or quit...
Multiple locations
Multiple locations
Research program evaluating the DNA of individuals, ages 16 to 65, with schizophrenia and other psychotic disorders.
Zucker Hillside Hospital | 75-59 263rd Street | Glen Oaks | NY 11004
Zucker Hillside Hospital | 75-59 263rd Street | Glen Oaks | NY 11004
This study is designed to assess a person’s eligibility for participation in any number of research studies being conducted at Northwell Health’s Zucker Hillside Hospital that require recruitment of healthy volunteers...
Zucker Hillside Hospital | 75-59 263rd Street | Glen Oaks | NY 11004
Zucker Hillside Hospital | 75-59 263rd Street | Glen Oaks | NY 11004
This is a longitudinal pharmacologic neuroimaging study in which we aim to characterize response to antipsychotic treatment over a twelve week period in patients with first episode psychosis...
Zucker Hillside Hospital | 75-59 263rd Street | Glen Oaks | NY 11004
Zucker Hillside Hospital | 75-59 263rd Street | Glen Oaks | NY 11004
This is a randomized, 24-week, double-blind study, comparing fluoxetine with aripiprazole in patients ages 12-25 presenting with attenuated positive symptoms at a level of at least moderate severity...
Zucker Hillside Hospital | 75-59 263rd Street | Glen Oaks | NY 11004
Zucker Hillside Hospital | 75-59 263rd Street | Glen Oaks | NY 11004
With this 16-week, randomized, double-blind study in stable patients ages 18 to 65, diagnosed with schizophrenia, we aim to assess the effect of adjunctive vortioxetine compared to placebo on negative symptoms measured with the Negative Symptom Assessment Scale (NSA-16)...
Zucker Hillside Hospital | 75-59 263rd Street | Glen Oaks | NY 11004
Zucker Hillside Hospital | 75-59 263rd Street | Glen Oaks | NY 11004
Researchers want to learn whether genetic and brain imaging biomarkers are useful in predicting treatment response to Clozapine therapy.
Participants will be interviewed, provide blood samples, be given neuropsychological tests, and undergo MRI scanning...
Zucker Hillside Hospital | 75-59 263rd Street | Glen Oaks | NY 11004
Zucker Hillside Hospital | 75-59 263rd Street | Glen Oaks | NY 11004
This is a 16-week, randomized, double-blind, parallel group, placebo-controlled study comparing adjunctive vortioxetine with identically appearing adjunctive placebo pills in 88 stable patients with a research diagnosis of schizophrenia determined with the Structured Clinical Interview for DSM (SCID)...
Multiple locations
Multiple locations
Project TAMMI is a no-cost research study that aims to evaluate a text-messaging service designed to help reduce alcohol use to healthier levels...
Center for Addiction Services and Personalized Interventions Research (CASPIR) | 1010 Northern Blvd | Great Neck | NY 11021
Center for Addiction Services and Personalized Interventions Research (CASPIR) | 1010 Northern Blvd | Great Neck | NY 11021
People with bipolar disorder often experience some symptoms before having a depressive or manic episode. This study aims to develop a method by which we could predict the onset of a mood episode by capturing these earlier symptom changes...
Zucker Hillside Hospital | 75-59 263rd Street | Glen Oaks | NY 11004
Zucker Hillside Hospital | 75-59 263rd Street | Glen Oaks | NY 11004